Silence Therapeutics plc Company Profile (LON:SLN)

About Silence Therapeutics plc (LON:SLN)

Silence Therapeutics plc logoSilence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a genetic toolkit with its own therapeutic payloads to modulate gene expression up as well as down in preclinical in vivo models, and delivery systems for various organs and cell types. The Company's RNA interference (RNAi) platform is AtuRNAi. AtuRNAi is based on specific small interfering RNA (siRNA) modules, stabilization technology and other tailored features. The Company's technology is in the clinic in a Phase IIa pancreatic cancer trial. The Company has developed modifications to improve the robustness of RNA sequences, together with advanced liposomal chemistries to enhance the delivery of therapeutic RNA molecules.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology & Medical Research - NEC
  • Sub-Industry: N/A
  • Symbol: LON:SLN
  • CUSIP: N/A
  • Web: silence-therapeutics.com
Capitalization:
  • Market Cap: £73.81 million
  • Outstanding Shares: 69,801,000
Average Prices:
  • 50 Day Moving Avg: GBX 98.35
  • 200 Day Moving Avg: GBX 94.17
  • 52 Week Range: GBX 71.88 - GBX 130
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: $769,999.00
  • Price / Sales: 95.86
  • Book Value: GBX 0.78 per share
  • Price / Book: 1.36
Profitability:
  • EBIDTA: ($11,600,000.00)
  • Net Margins: -481.43%
  • Return on Equity: -13.24%
  • Return on Assets: -12.88%
Misc:
  • Average Volume: 27,801 shs.
 

Frequently Asked Questions for Silence Therapeutics plc (LON:SLN)

What is Silence Therapeutics plc's stock symbol?

Silence Therapeutics plc trades on the London Stock Exchange (LON) under the ticker symbol "SLN."

When will Silence Therapeutics plc make its next earnings announcement?

Silence Therapeutics plc is scheduled to release their next quarterly earnings announcement on Monday, September, 25th 2017. View Earnings Estimates for Silence Therapeutics plc.

Where is Silence Therapeutics plc's stock going? Where will Silence Therapeutics plc's stock price be in 2017?

1 equities research analysts have issued 1-year price targets for Silence Therapeutics plc's stock. Their forecasts range from GBX 249 to GBX 249. On average, they anticipate Silence Therapeutics plc's stock price to reach GBX 249 in the next year. View Analyst Ratings for Silence Therapeutics plc.

Who are some of Silence Therapeutics plc's key competitors?

Who are Silence Therapeutics plc's key executives?

Silence Therapeutics plc's management team includes the folowing people:

  • Ali Mortazavi, Chief Executive Officer, Director
  • David Ellam, Chief Financial Officer, Director
  • Lars Karlsson, Head of Research and Development, Executive Director
  • Mark Cameron, Head of Chemistry
  • Stephen B. Parker, Independent Non-Executive Chairman of the Board
  • Stuart J.M. Collinson Ph.D., Non-Executive Director
  • Alistair William Gray, Non-Executive Director

How do I buy Silence Therapeutics plc stock?

Shares of Silence Therapeutics plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Silence Therapeutics plc's stock price today?

One share of Silence Therapeutics plc stock can currently be purchased for approximately GBX 105.75.


MarketBeat Community Rating for Silence Therapeutics plc (LON SLN)
Community Ranking:  2.9 out of 5 ( )
Outperform Votes:  50 (Vote Outperform)
Underperform Votes:  36 (Vote Underperform)
Total Votes:  86
MarketBeat's community ratings are surveys of what our community members think about Silence Therapeutics plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Silence Therapeutics plc (LON:SLN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 249

Analysts' Ratings History for Silence Therapeutics plc (LON:SLN)
Show:
DateFirmActionRatingPrice TargetDetails
1/9/2017Canaccord GenuityReiterated RatingBuyGBX 249View Rating Details
(Data available from 7/21/2015 forward)

Earnings

Earnings History for Silence Therapeutics plc (LON:SLN)
Earnings by Quarter for Silence Therapeutics plc (LON:SLN)
Earnings History by Quarter for Silence Therapeutics plc (LON SLN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/25/2017N/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Silence Therapeutics plc (LON:SLN)
Current Year EPS Consensus Estimate: $-14.90 EPS

Dividends

Dividend History for Silence Therapeutics plc (LON:SLN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Silence Therapeutics plc (LON:SLN)
Insider Trades by Quarter for Silence Therapeutics plc (LON:SLN)
Insider Trades by Quarter for Silence Therapeutics plc (LON:SLN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/18/2016Mortazavi,AliInsiderBuy160,000GBX 125£200,000
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Silence Therapeutics plc (LON:SLN)
Latest Headlines for Silence Therapeutics plc (LON:SLN)
Source:

Social

Social activity is not available for this stock.

Chart

Silence Therapeutics plc (SLN) Chart for Friday, July, 21, 2017

This page was last updated on 7/21/2017 by MarketBeat.com Staff